PPIST16847
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | GSHMQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY |
Peptide Information
| Peptide_Chain | B |
|---|---|
| Peptide_Sequence | LTERHKILHRLLQEG |
| Peptide_Length | 15 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 8HUM |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.29 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Functional and Structural Insights into the Human PPAR alpha / delta / gamma Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. |
|---|---|
| Release_Year | 2023 |
| PMID | 37627519 |
| DOI | 10.3390/antiox12081523 |